Evidence map›Paper›PMID 30574564›Full record

ReviewJournal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)2018

Abdominal Sepsis: An Update.

Mircea Gabriel Mureșan, Ioan Alexandru Balmoș, Iudita Badea, Ario Santini

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06901544 (Capillary Leak Index as a Prognostic Indicator for Post-Operative Abdominal Sepsis in Critically Ill Patients), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06901544 completednot on this mapstarted 2025, after this paper: background citation

Capillary Leak Index as a Prognostic Indicator for Post-Operative Abdominal Sepsis in Critically Ill Patients

Typeobservational_patient_registrySponsorAin Shams UniversityRan2025 to 2025Enrolled100ConditionsIntra-Abdominal Infections, Intestinal Obstruction, Appendicitis Acute, Perforated Viscus
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Efficacy ofFrontiers in cellular and infection microbiology · 2022
    Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mircea Gabriel MureșanUniversity of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Târgu Mureş Romania.
Ioan Alexandru BalmoșUniversity of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Târgu Mureş Romania.
Iudita BadeaUniversity of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Târgu Mureş Romania.
Ario SantiniUniversity of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Târgu Mureş Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the significant development and advancement in antibiotic therapy, life-threatening complication of infective diseases cause hundreds of thousands of deaths world. This paper updates some of the issues regarding the etiology and treatment of abdominal sepsis and summaries the latest guidelines as recommended by the Intra-abdominal Infection (IAI) Consensus (2017). Prognostic scores are currently used to assess the course of peritonitis. Irrespective of the initial cause, there are several measures universally accepted as contributing to an improved survival rate, with the early recognition of IAI being the critical matter in this respect. Immediate correction of fluid balance should be undertaken with the use of vasoactive agents being prescribed, if necessary, to augment and assist fluid resuscitation. The WISS study showed that mortality was significantly affected by sepsis irrespective of any medical and surgical measures. A significant issue is the prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in the clinical setting, and the reported prevalence of ESBLs intra-abdominal infections has steadily increased in Asia. Europe, Latin America, Middle East, North America, and South Pacific. Abdominal cavity pathology is second only to sepsis occurring in a pulmonary site. Following IAI (2017) guidelines, antibiotic therapy should be initiated as soon as possible after a diagnosis has been verified.

Indexed as

abdominal sepsisperitonitisseptic shock

Identifiers

PMID30574564
PMCPMC6296273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.